Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1598 studies found for:    "Alzheimer Disease"
Show Display Options
Rank Status Study
21 Completed Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: GSK239512;   Drug: Placebo
22 Completed Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TC-5619;   Drug: Placebo
23 Completed Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation
Condition: Alzheimer's Disease
Interventions: Other: Text-based task;   Other: Graphic-based Task
24 Completed
Has Results
Bexarotene Amyloid Treatment for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bexarotene;   Drug: Placebo
25 Recruiting Trial of Carvedilol in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Carvedilol;   Drug: Placebo
26 Completed
Has Results
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
27 Completed Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease
Condition: Alzheimer's Disease
Intervention: Drug: PPI-1019 (APAN)
28 Active, not recruiting ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Device: DBS-f on;   Device: DBS-f off
29 Completed Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-354;   Drug: Placebo
30 Terminated Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-957;   Other: Placebo for ABT-957
31 Recruiting Study to Evaluate Coconut Oil for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Coconut Oil Beverage;   Other: Placebo Beverage
32 Completed Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 1 mg/kg;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 5 mg/kg;   Biological: PF-04360365 10 mg/kg
33 Completed Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
34 Unknown  Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study
Condition: Alzheimer's Disease
Intervention: Drug: F18-AV45
35 Completed Lipitor as a Treatment for Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Atorvastatin calcium
36 Completed Alzheimer's Disease: Therapeutic Potential of Estrogen
Condition: Alzheimer Disease
Interventions: Drug: Transdermal estradiol;   Drug: Medroxyprogesterone;   Drug: Placebo Patch;   Drug: Placebo
37 Completed A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 10 mg/kg;   Biological: PF-04360365 7.5 mg/kg;   Drug: placebo
38 Not yet recruiting Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo Capsule(s) Once a Day by Mouth;   Drug: Nilotinib Capsule(s) Once a Day by Mouth
39 Recruiting Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Biological: Clinic and neuropsychologic evaluation;   Radiation: MRI;   Procedure: PET;   Biological: Apolipoprotein E genotyping;   Biological: Study of cerebrospinal fluid
40 Completed Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Behavioral: Standard intervention protocol;   Behavioral: Standard intervention protocol + Cognitive training therapy;   Behavioral: Standard intervention protocol + Reminiscence therapy;   Behavioral: Standard intervention protocol + "Made-to-measure" program

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.